
Truveta
Saving lives with data by providing regulatory-grade safety and effectiveness data.

Instant AI diabetic retinopathy diagnosis with handheld or tabletop cameras.

AEYE Health offers an FDA-cleared AI-powered solution for diabetic retinopathy (DR) screening. Their AEYE-DS system utilizes autonomous AI to analyze retinal images captured by portable and desktop cameras, providing on-the-spot diagnostic reports without requiring physician interpretation. This technology replaces the traditional referral process to specialists, closing the DR care gap. It can be integrated into primary care workflows, identifying patients with DR for timely treatment and preventing potential blindness. The system boasts high sensitivity and specificity, exceeding 90% in clinical trials. AEYE-X is an AI-based diagnostic screening tool designed for detecting a broad range of diseases from retinal images.
AEYE Health offers an FDA-cleared AI-powered solution for diabetic retinopathy (DR) screening.
Explore all tools that specialize in predict disease risk. This domain focus ensures AEYE Health delivers optimized results for this specific requirement.
Explore all tools that specialize in provide clinical decision support. This domain focus ensures AEYE Health delivers optimized results for this specific requirement.
Explore all tools that specialize in image analysis. This domain focus ensures AEYE Health delivers optimized results for this specific requirement.
AEYE-DS utilizes fully autonomous AI algorithms to analyze retinal images, eliminating the need for manual interpretation by specialists.
AEYE-DS is compatible with both portable (Optomed Aurora) and tabletop (Topcon) cameras, offering flexibility in deployment settings.
AEYE-DS is CPT 92229 reimbursable, allowing healthcare providers to bill for diabetic retinopathy screening services.
AEYE-DS demonstrates high sensitivity (92-93%) and specificity (89-94%) in detecting diabetic retinopathy, minimizing false positives and negatives.
AEYE-DS can be seamlessly integrated with existing electronic medical record (EMR) and electronic health record (EHR) systems.
AEYE-X utilizes AI to diagnose and predict the development of a broad range of diseases from retinal images, beyond just diabetic retinopathy.
Acquire AEYE-DS system with compatible camera (Optomed Aurora or Topcon).
Integrate AEYE-DS software with existing EMR/EHR systems.
Train staff on proper retinal image acquisition techniques.
Calibrate camera and software according to AEYE Health's guidelines.
Upload retinal images to AEYE-DS for AI analysis.
Review the on-the-spot diagnostic report generated by AEYE-DS.
Integrate diagnostic results into patient's medical record.
Schedule follow-up appointments based on the diagnosis.
All Set
Ready to go
Verified feedback from other users.
"AEYE Health receives positive reviews for its ease of use, accuracy, and ability to improve access to diabetic retinopathy screening."
Post questions, share tips, and help other users.

Saving lives with data by providing regulatory-grade safety and effectiveness data.

Breast AI trusted for better workflow and higher confidence in mammography screening.

Assistive communication solutions for people with disabilities.

Turn your diabetes data points into accessible, actionable, and meaningful insights.

Science-backed supplements for personalized wellness.

Hear everything in a heartbeat with advanced digital stethoscope technology.